Summary
The maker of a key bird flu drug said yesterday that sales of the treatment had more than doubled as countries stocked up ahead of a possible pandemic.
Swiss firm Roche said sales of Tamiflu, which is seen as the best treatment for bird flu, soared to 279 million Swiss francs (pounds 122 million) in its third quarter.See the full content of this document
Extract
Flu Pandemic Fears See Sales of Drug Double
A number of countries, including the UK, have been stockpiling the antiviral drug, helping Roche report a 17 per cent rise in group revenues in the three months t...
See the full content of this document
Sponsored links
